SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-295676
Filing Date
2013-07-19
Accepted
2013-07-19 16:28:55
Documents
5
Period of Report
2013-07-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d570668d8k.htm 8-K 22543
2 EX-1.1 d570668dex11.htm EX-1.1 181885
3 EX-5.1 d570668dex51.htm EX-5.1 5656
4 EX-99.1 d570668dex991.htm EX-99.1 237733
5 GRAPHIC g570668ex5_1p1.jpg GRAPHIC 6361
  Complete submission text file 0001193125-13-295676.txt   457800
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 13977295
SIC: 2834 Pharmaceutical Preparations